While there is a diverse armamentarium to serve as inhibitors of the osteoclastic activity, PTH was the first anabolic agent approved by the FDA (Food and Drug Administration (USA)) [5] for the treatment of osteoporosis in 2002. Here, PTH is linked to osteoporosis.